More Articles

Problematic patent settlements in EU on the decrease Reports | Posted 19/08/2011

The European Commission’s (EC) second monitoring exercise of patent settlements in the pharmaceutical sector has shown a continuing decline of potentially problematic settlements under EU antitrust...

Switching from a brand-name antiepileptic drug to a generic is not associated with a higher risk of seizures Generics/Research | Posted 19/08/2011

A report in Clinical Pharmacology and Therapeutics provides further evidence that patients with epilepsy do not have a higher risk of seizures if they switch from their brand-name anti-epileptic dr...

How successful is the reference pricing system in Belgium Generics/Research | Posted 19/08/2011

The main aim of a reference pricing system (RPS) is to provide generic medicines at the lowest cost to the state and individuals. This article explains how RPSs work and asks how the Belgian system...

GPs in the UK to be banned from prescribing branded statins Generics/News | Posted 19/08/2011

General Practitioners (GPs) in Cambridgeshire, UK, have been told by the national health service (NHS) that they are considering proposals to ban prescribing of branded statins in favour of cheaper...

A sustainable generics industry in the EU Reports | Posted 19/08/2011

Today, generic medicines play an essential role in treating disease by increasing the accessibility and affordability of modern day pharmaceuticals. It is therefore essential to ensure that generic...

FDA gives some insight into biosimilar pathway Biosimilars/News | Posted 12/08/2011

FDA has outlined some of the requirements it intends to include in its biosimilars approval process in an article published in the New England Journal of Medicine [1]. The article is intended to gi...

EMA proposes more precise definition for biosimilars Biosimilars/Research | Posted 12/08/2011

Members of the Biosimilar Medicinal Products Working Party at the EMA expressed the need to propose a more precise definition for biosimilars due to problems arising from imprecise usage of the ter...

Benefits of generics called into question Generics/Research | Posted 12/08/2011

The benefits associated with generic prescription drugs have been called into question in an article published in the British Medical Journal (BMJ) [1].